Stresser D M, Kupfer D
Department of Pharmacology and Molecular Toxicology, University of Massachusetts Medical Center, USA.
Drug Metab Dispos. 1998 Sep;26(9):868-74.
1,1,1-Trichloro-2,2-bis(4-methoxyphenyl)ethane (methoxychlor) is a widely used pesticide that is pro-estrogenic. We have elucidated the human cytochrome P450 enzymes responsible for conversion of methoxychlor into its major metabolite, the mono-O-demethylated derivative (mono-OH-M) that is estrogenic. Incubation of methoxychlor with microsomes from insect cells overexpressing either CYP1A2, CYP2C18, or CYP2C19 yielded mono-OH-M with turnover numbers of 14.9, 15.5, and 39.1 nmol/min/nmol of P450, respectively. CYP2B6 and CYP2C9 were much less active. Incubations with purified CYP2C19 and CYP2C18 resulted in formation of mono-OH-M, and also the bis-demethylated metabolite. Co-incubation of liver microsomes with methoxychlor and various P450 isoform-selective inhibitors suggested involvement of several P450s in mono-O-demethylation, including CYP1A2, CYP2A6, CYP2C9, and CYP2C19. A role for CYP2C19, CYP1A2, and CYP2A6 was also indicated by multivariate regression analysis of the mono-O-demethylase activity in a panel of human liver microsomes characterized for isoform-specific catalytic activities (R2 = 0.96). Based on the totality of the evidence, CYP2C19 appears to be the major catalyst of methoxychlor mono-O-demethylation. However, in individuals lacking functional CYP2C19 (e.g. the "poor metabolizer" phenotype), CYP1A2 may play the predominant role. CYP2A6, CYP2C9, and CYP2B6 probably contribute to a lesser extent. Although CYP2C18 is an efficient methoxychlor demethylase, its expression in liver is reportedly low or absent, suggesting a negligible role for this enzyme in methoxychlor metabolism. Lengthy incubations of liver microsomes with methoxychlor produced other secondary and tertiary metabolites. Efficient conversion of methoxychlor to estrogenic mono-OH-M by liver microsomes suggests that methoxychlor has the potential to be estrogenic in humans, as observed in several animal species.
1,1,1-三氯-2,2-双(4-甲氧基苯基)乙烷(甲氧滴滴涕)是一种广泛使用的具有雌激素活性的杀虫剂。我们已经阐明了负责将甲氧滴滴涕转化为其主要代谢产物——具有雌激素活性的单-O-去甲基化衍生物(单-OH-M)的人类细胞色素P450酶。将甲氧滴滴涕与过表达CYP1A2、CYP2C18或CYP2C19的昆虫细胞微粒体一起孵育,分别产生了周转数为14.9、15.5和39.1 nmol/分钟/ nmol P450的单-OH-M。CYP2B6和CYP2C9的活性要低得多。用纯化的CYP2C19和CYP2C18进行孵育导致形成单-OH-M以及双去甲基化代谢产物。肝微粒体与甲氧滴滴涕和各种P450同工型选择性抑制剂共同孵育表明,包括CYP1A2、CYP2A6、CYP2C9和CYP2C19在内的几种P450参与了单-O-去甲基化。对一组以同工型特异性催化活性为特征的人肝微粒体中的单-O-去甲基酶活性进行多变量回归分析,也表明CYP2C19、CYP1A2和CYP2A6发挥了作用(R2 = 0.9)。基于所有证据,CYP2C19似乎是甲氧滴滴涕单-O-去甲基化的主要催化剂。然而,在缺乏功能性CYP2C19的个体(例如“代谢缓慢者”表型)中,CYP1A2可能起主要作用。CYP2A6、CYP2C9和CYP2B6的贡献可能较小。尽管CYP2C18是一种有效的甲氧滴滴涕去甲基酶,但据报道其在肝脏中的表达很低或不存在,这表明该酶在甲氧滴滴涕代谢中的作用可以忽略不计。肝微粒体与甲氧滴滴涕长时间孵育会产生其他二级和三级代谢产物。肝微粒体将甲氧滴滴涕高效转化为具有雌激素活性的单-OH-M,这表明甲氧滴滴涕在人类中具有产生雌激素活性的潜力,正如在几种动物物种中观察到的那样。